SBT12DLMFPPC

Alarms, Buzzers, And Sirens Overview

The SBT12DLMFPPC is an industrial-grade audio indicator manufactured by Mallory Sonalert. It operates within a voltage range of 9 to 12 VDC and produces a sound pressure level of 100 dB. The device features a Drug-Fluid melody tone, designed for specific medical or industrial signaling applications. It complies with RoHS standards and is supplied in a stick pack configuration.

Alarms, Buzzers, And Sirens Feature Summary

• Generates a distinct Drug-Fluid melody tone for clear auditory identification
• Operates on standard 9-12 VDC power supply
• Complies with RoHS environmental directives

Alarms, Buzzers, And Sirens Applications

• Medical equipment alarm systems
• Industrial control panel indicators
• Safety warning devices requiring specific melodic alerts

Alarms, Buzzers, And Sirens Procurement Notes

Verify the exact part number against official Mallory Sonalert documentation before procurement. Confirm that the suffix PP indicates the correct packaging type required for your assembly process. Ensure the 9-12VDC operating voltage matches your system design specifications to prevent malfunction.

Alarms, Buzzers, And Sirens Selection Notes

Select this component when a high-intensity 100 dB output is required alongside a specific Drug-Fluid melody. Compare against other SBT series variants to ensure the voltage and acoustic profile align with the target application's regulatory and functional requirements.

Alarms, Buzzers, And Sirens Part Context

This unit belongs to the Mallory Sonalert SBT series of piezoelectric buzzers. These components are engineered for reliability in demanding environments. The SBT12DLMFPPC specifically utilizes the 12V class housing with specialized acoustic tuning for the designated melody.

Alarms, Buzzers, And Sirens Replacement Considerations

Direct substitutes include other Mallory Sonalert parts with identical voltage, decibel rating, and melody codes. Verify mechanical mounting dimensions and electrical polarity compatibility before swapping with generic alternatives.